Company profile

Chipscreen Biosciences

Diversified pharma

688321 · SSE · China

Public Market Listing

688321SSE

SSE primary exchange listing

Live quotes, historical charts, and market capitalization for Chipscreen Biosciences are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(4 total)
4Total Assets
0Approved
2Phase 3 / Filed
2Phase 1–2 / Early
3Diseases
Quick filter:
Showing 4 of 4 assets
Target & Modality
Chidamide
Phase 3
HDACSmall molecule
Non-Small Cell Lung Cancer
Chiglitazar(Bilessglu)
Phase 3
PPAR (pan-agonist)Small molecule
Type 2 Diabetes
CS32582
Phase 2
TYK2Small molecule
Psoriasis
CS08399
Phase 1
PRMT5 (protein arginine methyltransferase 5), MTA-cooperativeSmall molecule
Non-Small Cell Lung Cancer

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.